You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 1 Issues Articles
Popular Type 1 Issues Articles
Highly Recommended Type 1 Issues Articles
Send a link to this page to your friends and colleagues.
Emisphere Technologies Inc., of Tarrytown, New Jersey announced the results of three phase I studies for two new medications for the oral delivery of insulin. Representatives, who presented the data at Investor Day In New York City and released a written statement on September 7, said the trials showed that the drugs were successfully absorbed from the gastrointestinal tract and significantly reduced blood glucose levels in study subjects.
"We are extremely excited about the data from all three studies," said Alan C. Moses, MD, chief medical officer and senior vice president, Joslin Diabetes Center, during the presentation. "Besides demonstrating insulin absorption in the gastrointenstinal tract, the studies were able to demonstrate a reduction in blood sugar levels. If oral insulin can be developed successfully, it will provide patients with diabetes a highly desirable option for insulin delivery that can be used early in type 2 diabetes and that can be used in combination with a single long-acting injection of insulin in type 1 diabetes."
0 comments - Nov 1, 2001
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.